The Autosomal Dominant Polycystic Kidney Disease Treatment Market is evolving through advancements in targeted pharmaceutical therapies and clinical research. ADPKD requires continuous medical attention because kidney cysts can progressively increase in size and number, potentially resulting in declining kidney function. Pharmaceutical companies are investing in research to identify innovative...
